JasmohanSBajajMD

Hepatology & Liver Transplantation

Associate Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine

Join to view full profile

Dr. Bajaj is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bajaj's full profile

Already have an account?

Office
1250 E Marshall St
Internal Medicine
Richmond, VA 23298
Phone+1 804-828-8508

Fax+1 804-828-5348

Education & Training

Medical College of Wisconsin Affiliated HospitalsFellowship, Gastroenterology, 2002 - 2005
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1999 - 2002
Maulana Azad Medical CollegeClass of 1998

Certifications & Licensure

VA State Medical License 2008 - 2026
WI State Medical License 2003 - 2025
American Board of Internal Medicine Gastroenterology
American Board of Internal Medicine Transplant Hepatology

Clinical Trials

Effect of Yogurt on Minimal Hepatic Encephalopathy Start of enrollment: 2005 Nov 01
Completed
Not Applicable
Rifaximin in Minimal Hepatic Encephalopathy Start of enrollment: 2007 Oct 01
Completed
Not Applicable
Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy Start of enrollment: 2009 Oct 01
Completed
Phase 1
Study of Rifaximin in Minimal Hepatic Encephalopathy Start of enrollment: 2010 Feb 01
Completed
Phase 1, Phase 2
Proton Pump Inhibitors and Dysbiosis in Cirrhosis Start of enrollment: 2011 Oct 01
Completed
Not Applicable
Effect of Tolvaptan on Cognitive Function in Cirrhosis Start of enrollment: 2011 Apr 01
Completed
Phase 3
Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy Start of enrollment: 2013 Apr 03
Terminated
Phase 4
iPod Games in Hepatic Encephalopathy Start of enrollment: 2013 Jan 01
Completed
Not Applicable
Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis Start of enrollment: 2015 Aug 01
Completed
Fecal Transplant in Recurrent Hepatic Encephalopathy Start of enrollment: 2015 Oct 01
Completed
Phase 1
Mindfulness and Support Group to Improve Patient and Caregiver Burden in Cirrhosis Start of enrollment: 2016 Jun 01
Completed
Not Applicable
Oral Gut Liver Axis in Cirrhosis Start of enrollment: 2016 Oct 01
Completed
Not Applicable
Ramelteon for Treatment of Insomnia in Cirrhosis Start of enrollment: 2017 Feb 01
Completed
Phase 4
Oral Fecal Transplant in Cirrhosis Start of enrollment: 2017 Jun 12
Completed
Phase 1
Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis Start of enrollment: 2018 Feb 01
Completed
Phase 1
Health IT Generated PROs to Improve Outcomes in Cirrhosis Start of enrollment: 2018 Jun 22
Completed
Not Applicable
FMT in Cirrhosis and Hepatic Encephalopathy Start of enrollment: 2019 Jul 29
Completed
Phase 1, Phase 2
Rifamycin in Minimal Hepatic Encephalopathy Start of enrollment: 2019 Sep 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

85 citations
Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.
Jasmohan S. Bajaj, Scott M. Ratliff, Douglas M. Heuman, Kate L. Lapane
Alimentary Pharmacology & Therapeutics. 2012-11-01
2 citations
Corrigendum to "Management of the critically ill patients with cirrhosis: A multidisciplinary perspective".
Mitra K. Nadim, François Durand, John A. Kellum, Josh Levitsky, Jacqueline G. O'Leary
Journal of Hepatology. 2016-08-01
184 citations
New Consensus Definition of Acute Kidney Injury Accurately Predicts 30-Day Mortality in Patients With Cirrhosis and Infection
Florence Wong, Jacqueline G. O'Leary, K. Rajender Reddy, Heather Patton, Patrick S. Kamath
Gastroenterology. 2013-12-01

Journal Articles

Reply (To LTE HEP‐18‐1401)
Patrick S Kamath, Jasmohan S Bajaj, Hepatology
The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients with Cirrhosis
Jasmohan S Bajaj, Jennifer C Lai, Scott W Biggins, Patrick S Kamath, Paul Thuluvath, Ram M Subramanian, Nature
Proton Pump Inhibitor Initiation and Withdrawal Affects Gut Microbiota and Readmission Risk in Cirrhosis
Michael Fuchs, Puneet Puri, Mohammad S Siddiqui, Douglas M Heuman, Jasmohan S Bajaj, Arun J Sanyal, Velimir Luketic, Richard K Sterling, Nature

Other

Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients with Cirrhosis
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/a2c73277-6791-46c4-90de-cff1de1d0b85
UpToDate, Wolters Kluwer Health - 2012-11-20
Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients with Cirrhosis
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/a2c73277-6791-46c4-90de-cff1de1d0b85
UpToDate, Wolters Kluwer Health - 2012-06-27
Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients with Cirrhosis
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/a2c73277-6791-46c4-90de-cff1de1d0b85
UpToDate, Wolters Kluwer Health - 2012-12-17
Current Management of Hepatic Encephalopathy
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/e9f24f02-2d3c-4402-9aef-fc842953291b
UpToDate, Wolters Kluwer Health - 2012-10-18
Current Management of Hepatic Encephalopathy
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/e9f24f02-2d3c-4402-9aef-fc842953291b
UpToDate, Wolters Kluwer Health - 2013-04-05
Current Management of Hepatic Encephalopathy
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/e9f24f02-2d3c-4402-9aef-fc842953291b
UpToDate, Wolters Kluwer Health - 2013-04-05
Join now to see all

Press Mentions

GENFIT Announces Corporate Updates and Upcoming Participation at the Liver Meeting® 2024November 13th, 2024
Promising New Data for Drugs Both Novel and Established in Several Common GI ConditionsNovember 7th, 2024
ACG: Fewer Overt Hepatic Encephalopathy Episodes Seen with RifaximinOctober 29th, 2024
Join now to see all

Grant Support

Spectrum Of Neuro-Cognitive Impairment In CirrhosisNational Institute Of Diabetes And Digestive And Kidney Diseases2011–2012
Hepatic Encephalopathy In Alcoholic Cirrhosis: A Systems Biology ApproachNational Institute On Alcohol Abuse And Alcoholism2010–2011
Probiotic Yogurt For The Treatment Of Minimal Hepatic EncephalopathyNational Center For Complementary &Alternative Medicine2009–2011
The Natural History Of Minimal Hepatic Encephalopathy And Its Effect On PsycNational Center For Research Resources2009–2010
Yogurt StudyNational Center For Research Resources2006